These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18402339)
1. [Pathophysiological role of aldosterone in acute renal failure]. Bobadilla NA Rev Invest Clin; 2007; 59(6):470-80. PubMed ID: 18402339 [No Abstract] [Full Text] [Related]
2. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527 [No Abstract] [Full Text] [Related]
3. Eplerenone in the treatment of chronic heart failure. Krum H; Liew D Expert Rev Cardiovasc Ther; 2004 May; 2(3):315-20. PubMed ID: 15151479 [TBL] [Abstract][Full Text] [Related]
4. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers. Aaronson K Health News; 2003 May; 9(5):4. PubMed ID: 12739453 [No Abstract] [Full Text] [Related]
5. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Mejía-Vilet JM; Ramírez V; Cruz C; Uribe N; Gamba G; Bobadilla NA Am J Physiol Renal Physiol; 2007 Jul; 293(1):F78-86. PubMed ID: 17376767 [TBL] [Abstract][Full Text] [Related]
11. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520 [TBL] [Abstract][Full Text] [Related]
12. [Efficient improvement of prognosis after myocardial infarct? Additional aldosterone inhibition is required]. MMW Fortschr Med; 2005 Dec; 147(48):66-7. PubMed ID: 16392155 [No Abstract] [Full Text] [Related]
13. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Struthers AD; MacDonald TM Cardiovasc Res; 2004 Mar; 61(4):663-70. PubMed ID: 14985063 [TBL] [Abstract][Full Text] [Related]
14. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946 [TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization. Yamada M; Kushibiki M; Osanai T; Tomita H; Okumura K Cardiovasc Res; 2008 Jul; 79(1):169-78. PubMed ID: 18326554 [TBL] [Abstract][Full Text] [Related]
16. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
17. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data. Black HR Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068 [TBL] [Abstract][Full Text] [Related]
18. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts. Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Jaffe IZ; Mendelsohn ME Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497 [TBL] [Abstract][Full Text] [Related]
20. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]